Short Interest in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Declines By 76.3%

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) was the recipient of a large decline in short interest in May. As of May 15th, there was short interest totaling 792 shares, a decline of 76.3% from the April 30th total of 3,341 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average trading volume of 17,047 shares, the short-interest ratio is currently 0.0 days.

Institutional Investors Weigh In On Invesco Pharmaceuticals ETF

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Jones Financial Companies Lllp lifted its holdings in shares of Invesco Pharmaceuticals ETF by 11.6% during the first quarter. Jones Financial Companies Lllp now owns 2,428 shares of the company’s stock valued at $210,000 after purchasing an additional 252 shares during the last quarter. BNP Paribas Financial Markets purchased a new stake in shares of Invesco Pharmaceuticals ETF during the second quarter valued at $799,000. Tower Research Capital LLC TRC lifted its holdings in shares of Invesco Pharmaceuticals ETF by 102.9% during the second quarter. Tower Research Capital LLC TRC now owns 4,680 shares of the company’s stock valued at $374,000 after purchasing an additional 2,374 shares during the last quarter. Ameriprise Financial Inc. lifted its holdings in shares of Invesco Pharmaceuticals ETF by 214.4% during the third quarter. Ameriprise Financial Inc. now owns 12,236 shares of the company’s stock valued at $1,114,000 after purchasing an additional 8,344 shares during the last quarter. Finally, Citadel Advisors LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF during the third quarter valued at $504,000.

Invesco Pharmaceuticals ETF Trading Down 0.8%

PJP stock traded down $0.86 during midday trading on Friday, hitting $109.63. 4,873 shares of the company’s stock were exchanged, compared to its average volume of 35,898. Invesco Pharmaceuticals ETF has a 12-month low of $78.77 and a 12-month high of $110.81. The firm has a 50 day moving average price of $104.90 and a 200-day moving average price of $105.55. The stock has a market capitalization of $358.49 million, a price-to-earnings ratio of 15.59 and a beta of 0.46.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.